| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 17850376
[patent_doc_number] => 20220280417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Antipsychotic Injectable Depot Composition
[patent_app_type] => utility
[patent_app_number] => 17/746647
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17746647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/746647 | Antipsychotic injectable depot composition | May 16, 2022 | Issued |
Array
(
[id] => 18018149
[patent_doc_number] => 20220369648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => ENDOPHYTIC FALCIPHORA ORYZAE FO-R20 AND ITS APPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/744713
[patent_app_country] => US
[patent_app_date] => 2022-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744713 | Endophytic falciphora oryzae FO-R20 and its application | May 14, 2022 | Issued |
Array
(
[id] => 19316858
[patent_doc_number] => 20240238398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => IMMUNOGENIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/560137
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560137
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/560137 | IMMUNOGENIC COMPOSITION | May 10, 2022 | Pending |
Array
(
[id] => 19279821
[patent_doc_number] => 20240216293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => USE OF PERILLYL ALCOHOL TO ENHANCE LEVO-DOPA DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/557650
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557650
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557650 | USE OF PERILLYL ALCOHOL TO ENHANCE LEVO-DOPA DELIVERY | Apr 27, 2022 | Pending |
Array
(
[id] => 17790416
[patent_doc_number] => 20220249507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 17/725772
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725772 | PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM | Apr 20, 2022 | Abandoned |
Array
(
[id] => 17774915
[patent_doc_number] => 20220241264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => METHODS FOR PREVENTION AND TREATMENT OF FIBROMYALGIA BY CONTACT VASODILATORS
[patent_app_type] => utility
[patent_app_number] => 17/721742
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17721742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/721742 | METHODS FOR PREVENTION AND TREATMENT OF FIBROMYALGIA BY CONTACT VASODILATORS | Apr 14, 2022 | Abandoned |
Array
(
[id] => 17790404
[patent_doc_number] => 20220249495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
[patent_app_type] => utility
[patent_app_number] => 17/719686
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719686 | Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations | Apr 12, 2022 | Abandoned |
Array
(
[id] => 19201356
[patent_doc_number] => 20240173255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => Polymeric Micelle Coated with Chain-Like Poorly Soluble Drug, Preparation Method and Application
[patent_app_type] => utility
[patent_app_number] => 18/286843
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286843 | Polymeric Micelle Coated with Chain-Like Poorly Soluble Drug, Preparation Method and Application | Apr 12, 2022 | Pending |
Array
(
[id] => 19215463
[patent_doc_number] => 20240180167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => POMACE LEACHATE HERBICIDE COMPOSITION AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/555277
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555277
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555277 | POMACE LEACHATE HERBICIDE COMPOSITION AND METHODS | Apr 12, 2022 | Pending |
Array
(
[id] => 17944378
[patent_doc_number] => 20220331395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => EXTENDED-RELEASE INJECTABLE GEL FORMULATIONS CONTAINING ANGIOTENSIN-(1-7) OLIGOPEPTIDES OR VARIANTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/715724
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715724 | EXTENDED-RELEASE INJECTABLE GEL FORMULATIONS CONTAINING ANGIOTENSIN-(1-7) OLIGOPEPTIDES OR VARIANTS THEREOF | Apr 6, 2022 | Pending |
Array
(
[id] => 19186151
[patent_doc_number] => 20240165064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => LONG-LASTING RESORBABLE SUBCUTANEOUS IMPLANT WITH PROLONGED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF HYPOTHYROIDISM, AND METHOD
[patent_app_type] => utility
[patent_app_number] => 18/552884
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552884 | LONG-LASTING RESORBABLE SUBCUTANEOUS IMPLANT WITH PROLONGED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF HYPOTHYROIDISM, AND METHOD | Mar 27, 2022 | Pending |
Array
(
[id] => 19185465
[patent_doc_number] => 20240164378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => SYNERGISTIC PLANT GROWTH STIMULANT COMPOSITIONS OF POTASSIUM MONO/DI-FORMATE WITH CARBOXYLIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/551823
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551823
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551823 | SYNERGISTIC PLANT GROWTH STIMULANT COMPOSITIONS OF POTASSIUM MONO/DI-FORMATE WITH CARBOXYLIC ACIDS | Mar 24, 2022 | Pending |
Array
(
[id] => 19245920
[patent_doc_number] => 20240196901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => Zinc and Boron Containing Enhanced Wood Preservative
[patent_app_type] => utility
[patent_app_number] => 18/551218
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551218
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551218 | Zinc and Boron Containing Enhanced Wood Preservative | Mar 17, 2022 | Pending |
Array
(
[id] => 18223285
[patent_doc_number] => 20230062279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF BORTEZOMIB
[patent_app_type] => utility
[patent_app_number] => 17/698537
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698537 | PHARMACEUTICAL COMPOSITIONS OF BORTEZOMIB | Mar 17, 2022 | Abandoned |
Array
(
[id] => 19139658
[patent_doc_number] => 20240138420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => A COMPOSITION AND PROCESS FOR IMPROVING A PLANT'S ABILITY TO REDUCE ATMOSPHERIC CO2
[patent_app_type] => utility
[patent_app_number] => 18/280170
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280170
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280170 | A COMPOSITION AND PROCESS FOR IMPROVING A PLANT'S ABILITY TO REDUCE ATMOSPHERIC CO2 | Mar 2, 2022 | Pending |
Array
(
[id] => 19127374
[patent_doc_number] => 20240132727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => MOLECULAR ASSEMBLY, USE OF THE MOLECULAR ASSEMBLY FOR PROVIDING ANTI-ADHESIVE SURFACES, AND METHOD FOR APPLYING THE MOLECULAR ASSEMBLY TO A SOLID SURFACE
[patent_app_type] => utility
[patent_app_number] => 18/279007
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279007
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279007 | MOLECULAR ASSEMBLY, USE OF THE MOLECULAR ASSEMBLY FOR PROVIDING ANTI-ADHESIVE SURFACES, AND METHOD FOR APPLYING THE MOLECULAR ASSEMBLY TO A SOLID SURFACE | Feb 22, 2022 | Pending |
Array
(
[id] => 19127374
[patent_doc_number] => 20240132727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => MOLECULAR ASSEMBLY, USE OF THE MOLECULAR ASSEMBLY FOR PROVIDING ANTI-ADHESIVE SURFACES, AND METHOD FOR APPLYING THE MOLECULAR ASSEMBLY TO A SOLID SURFACE
[patent_app_type] => utility
[patent_app_number] => 18/279007
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279007
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279007 | MOLECULAR ASSEMBLY, USE OF THE MOLECULAR ASSEMBLY FOR PROVIDING ANTI-ADHESIVE SURFACES, AND METHOD FOR APPLYING THE MOLECULAR ASSEMBLY TO A SOLID SURFACE | Feb 22, 2022 | Pending |
Array
(
[id] => 19140310
[patent_doc_number] => 20240139085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => SURFACE-MODIFIED ZINC OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC PREPARATION, AND METHOD FOR PRODUCING SURFACE-MODIFIED ZINC OXIDE PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/278176
[patent_app_country] => US
[patent_app_date] => 2022-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278176
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278176 | SURFACE-MODIFIED ZINC OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC PREPARATION, AND METHOD FOR PRODUCING SURFACE-MODIFIED ZINC OXIDE PARTICLES | Feb 20, 2022 | Pending |
Array
(
[id] => 19155941
[patent_doc_number] => 20240148647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => AN EFLORNITHINE COMPOSITION FOR INHIBITING HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 18/547025
[patent_app_country] => US
[patent_app_date] => 2022-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547025
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547025 | AN EFLORNITHINE COMPOSITION FOR INHIBITING HAIR GROWTH | Feb 18, 2022 | Pending |
Array
(
[id] => 17640583
[patent_doc_number] => 20220168321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/675780
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675780 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | Feb 17, 2022 | Issued |